Diversity, equity & inclusion

Female scientists are now quantitatively not getting the credit they deserve, according to a new study published in the scientific journal Nature.

Decentralized clinical trials may cost more upfront, but can have huge returns on the back end, according to speakers at Informa Connect’s Decentralized Clinical Trials meeting.

Representation of women in biotech is nearing parity, but this is not reaching the executive level, where there is still stark disparity.

Black/African American hematological cancer patients tend to have the worst outcomes. This is partly driven by a lack of access to allogeneic hematopoietic stem cell transplant and available donors.

The study revealed that Yescarta was both safe and effective in adult patients regardless of race and ethnicity.

BioSpace looks at the challenges faced by the Latinx community in the life sciences, from the origins of the challenges, to educational gain and the importance of mentorship.

This summer, BioSpace will release a series of reports looking at the current state of diversity and inclusion in the life sciences.

Despite a historic push for greater diversity and inclusion (D&I), a significant disconnect prevails between good intentions and actual lived experiences.

Diversity and Inclusion (D&I) have been at the forefront of the national conversation during this momentous year, so BioSpace felt it imperative to reach out to employees in the life sciences industry on this subject in our wide-ranging Fall 2020 Diversity and Inclusion Survey.

Let’s review the reasons why professionals seek out employers with diverse workforces.